Global Neurology Academy - Global Neurology Academy

Global Neurology Academy

Global Neurology Academy

Enhance your practice with CME
and tools that focus on the management
of neurological conditions.

Popular

Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
CME/CE
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
0.25 credits
- Dani Cabral, MD
0.25 credits
Uncovering TK2d: How to Navigate Diagnostic Challenges
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiers
Uncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
- Kaitlin Batley, MD
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CE
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
0.25 credits
- R. Scott Turner, MD, PhD
0.25 credits
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiers
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
- Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Implementing Cognitive Screening in MS Care
NeuroFrontiers
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
- Elizabeth S. Gromisch, PhD
Precision Medicine for Myasthenia Gravis
Precision Medicine for Myasthenia Gravis
NeuroFrontiers
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiers
Immunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS
The New Era of Targeted Therapy for Myasthenia Gravis
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiers
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
- Shruti Raja, MD, MHS

Medical News

Medical News
SCC-DBS Pathway Engagement Linked to Depression Response
10/23/2026
Read more
Medical News
Dystonia in PSP: Subtype Patterns and MRI Associations
10/20/2026
Read more
Medical News
EEG Window Leakage Inflates ADHD and Parkinson's Scores
10/20/2026
Read more
Medical News
GFAP and NfL Fall During C5 Inhibition in NMOSD
10/13/2026
Read more

CME/CE

Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
CME/CE
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS; Valeria Caso, MD, PhD
0.75 credits
- C. Michael Gibson, MD, MS
- Valeria Caso, MD, PhD
- Ashkan Shoamanesh, MD
0.75 credits
Recurrence as the Rule: BD Symptoms Persist and Cycle
Recurrence as the Rule: BD Symptoms Persist and Cycle
MinuteCE®
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits
MinuteCE®
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 credits 5 episodes
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 credits 5 episodes
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
MinuteCE®
Modulating the Bipolar Circuit: Striatal Dopamine and the Muscarinic Opportunity
Jose M. Rubio, MD, PhD; Sunny X. Tang, MD
0.50 program credits
- Jose M. Rubio, MD, PhD
- Sunny X. Tang, MD
0.50 program credits

Clinical Practice

Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiers
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
- Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
A Closer Look at the Biology Behind MS Progression
NeuroFrontiers
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
- Ethan Meltzer, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
Exploring Genetic Links Between EBV Clearance and MS Risk
NeuroFrontiers
Exploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
- David Hafler, MD, FANA, MSc
Navigating Emerging Treatment Options in MG
Navigating Emerging Treatment Options in MG
NeuroFrontiers
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
- Qihua Fan, MD

Programs

Recognizing the Signs of TK2 Deficiency
Recognizing the Signs of TK2 Deficiency
NeuroFrontiers
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
- Kaitlin Batley, MD
Navigating Emerging Biomarkers in MS Care
Navigating Emerging Biomarkers in MS Care
NeuroFrontiers
Navigating Emerging Biomarkers in MS Care
Ethan Meltzer, MD
- Ethan Meltzer, MD
New Therapies, New Strategy: Rethinking MG Inpatient Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiers
New Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
- Qihua Fan, MD
Outcome Measures Capture Progression in Late-Onset TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
NeuroFrontiers
Outcome Measures Capture Progression in Late-Onset TK2d